WILLIAM PEACOCK to Clinical Trials as Topic
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Clinical Trials as Topic.
Connection Strength
0.418
-
Central versus local adjudication of myocardial infarction in a cardiac biomarker trial. Am Heart J. 2013 Mar; 165(3):273-279.e1.
Score: 0.075
-
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation. Vasc Health Risk Manag. 2009; 5:783-91.
Score: 0.059
-
The rationale for an acute heart failure syndromes clinical trials network. J Card Fail. 2009 Aug; 15(6):467-74.
Score: 0.057
-
Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther. 2008 Jul-Aug; 15(4):299-303.
Score: 0.055
-
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24.
Score: 0.053
-
Clinical and economic impact of nesiritide. Am J Health Syst Pharm. 2003 Aug 15; 60 Suppl 4:S21-6.
Score: 0.039
-
Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies. Eur Heart J. 2015 Mar 21; 36(12):715-23.
Score: 0.022
-
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia. Expert Opin Pharmacother. 2015; 16(11):1727-34.
Score: 0.021
-
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med. 2015 Jan; 22(1):94-112.
Score: 0.021
-
International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes. Eur J Heart Fail. 2010 Nov; 12(11):1253-60.
Score: 0.016